Jan Møller Mikkelsen

Board of Directors, Ascendis Pharma Endocrinology Division A/S

Soløsevej 24DK10 active roles

Jan Møller Mikkelsen is a Danish director with 10 active roles across Danish companies, including Board of Directors at Ascendis Pharma Endocrinology Division A/S.

Overview

Active roles

directorships & management

Past roles

historical positions

Dissolved companies

in directorship history

Career timeline

2026 – now
Founder, Cadenza Partners 2 ApS
2023 – now
Board of Directors, Ascendis Pharma Europe A/S
2023 – 2024
Board of Directors, Ascendis Pharma Nordics A/S
2019 – now
Board of Directors, Ascendis Pharma Oncology Division A/S
2019 – now
Chief Executive Officer, CADENZA PARTNERS ApS
2012 – now
Board of Directors, Ascendis Pharma Endocrinology Division A/S
2012 – now
Board of Directors, ASCENDIS PHARMA BONE DISEASES A/S
2012 – now
Board of Directors, ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S
2012 – now
Board of Directors, Ascendis Pharma Growth Disorders A/S
2006 – now
Founder, ASCENDIS PHARMA A/S
2006 – 2015
Chairman, NEURONICON ApS
2005 – now
Stakeholder, Tobias Mikkelsen
2003 – 2006
Chief Executive Officer, VELOXIS PHARMACEUTICALS A/S
2003 – 2005
Chairman, HYSCITE DISCOVERY A/S
2001 – 2006
Deputy, 7TM A/S
2001 – 2002
Board of Directors, NUEVOLUTION A/S
2001 – 2001
Founder, NORDIC BIOTECH INCENTIVE ApS
2000 – 2009
Management, PROFOUND INVEST A/S
1999 – 2001
Chief Executive Officer, MAXYGEN ApS

Personal details

Nationality

Address

Soløsevej 24

Jan Møller Mikkelsen

Overview

Career timeline

Personal details

More on Jan Møller Mikkelsen

Overview

Career timeline

Personal details

More on Jan Møller Mikkelsen